Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc.

NEUP
Neuphoria Therapeutics Inc.US flagNASDAQ Global Market
Neuphoria Therapeutics Inc.
NEUP
(NASDAQ Global Market)

Recent

price

4.36

P/E

ratio

-54.5

div

yld

- -

ROIC.AI

Capital Structure

in mil. unless spec.
Working Capital

in mil. unless spec.
Growth Rates

in mil. unless spec.
Quarterly Revenue

in mil. unless spec.
Quarterly Earnings Per Share

in mil. unless spec.
Quarterly Dividends Per Share

in mil. unless spec.
Similar Companies
Business
Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.

Company News

  • Here's Why Momentum in Neuphoria Therapeutics Inc. (NEUP) Should Keep going

  • Neuphoria Completes Re-domiciliation and Successor Listing on Nasdaq